Curanex Pharmaceuticals Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -35 | 15 | -15 | |
EBITDA | -3,148 | 1,177 | -934 | -42 |
EBIT | -3,183 | 1,143 | -949 | -57 |
Net Income | -3,150 | -3,073 | -954 | -60 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -954 | -857 | -9,187 | -290 |
Cash | 4,018 | 4,973 | 5,830 | 108 |
Basic Shares | 28,344 | 25,497 | 25,599 | 27,750 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $26 |
Gross Profit | 0 | 4 | ||
EBITDA | 79 | -290 | -17 | |
EBIT | 0 | -19 | -20 | |
Net Income | -4,225 | -361 | -19 | -20 |
Net Change In Cash | 0 | 0 | 0 | 26 |
Free Cash Flow | -10,484 | -555 | 3 | |
Cash | 4,973 | 148 | 74 | 2 |
Basic Shares | 25,497 | 27,750 | 42,000 | 42,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.11 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.04 |
2025-06-30 | -$0.01 |